|
Background Earlier trials have shown that a routine invasive strategy improves outcomes in patients with acute coronary syndromes without ST-segment elevation. However, the optimal timing of such intervention remains uncertain.
Methods We randomly assigned 3031 patients with acute coronary syndromes to undergo either routine early intervention (coronary angiography
Results Coronary angiography was performed in 97.6% of patients in the early-intervention group (median time, 14 hours) and in 95.7% of patients in the delayed-intervention group (median time, 50 hours). At 6 months, the primary outcome occurred in 9.6% of patients in the early-intervention group, as compared with 11.3% in the delayed-intervention group (hazard ratio in the early-intervention group, 0.85; 95% confidence interval [CI], 0.68 to 1.06; P=0.15). There was a relative reduction of 28% in the secondary outcome of death, myocardial infarction, or refractory ischemia in the early-intervention group (9.5%), as compared with the delayed-intervention group (12.9%) (hazard ratio, 0.72; 95% CI, 0.58 to 0.89; P=0.003). Prespecified analyses showed that early intervention improved the primary outcome in the third of patients who were at highest risk (hazard ratio, 0.65; 95% CI, 0.48 to 0.89) but not in the two thirds at low-to-intermediate risk (hazard ratio, 1.12; 95% CI, 0.81 to 1.56; P=0.01 for heterogeneity).
Conclusions Early intervention did not differ greatly from delayed intervention in preventing the primary outcome, but it did reduce the rate of the composite secondary outcome of death, myocardial infarction, or refractory ischemia and was superior to delayed intervention in high-risk patients. (ClinicalTrials.gov number, NCT00552513
[ClinicalTrials.gov]
.)
24 hours after randomization) or delayed intervention (coronary angiography
36 hours after randomization). The primary outcome was a composite of death, myocardial infarction, or stroke at 6 months. A prespecified secondary outcome was death, myocardial infarction, or refractory ischemia at 6 months.
Source Information
From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada (S.R.M., R.A., S.C., S.S.J., M.K.N., C.H., S.Y.); Duke Clinical Research Institute, Durham, NC (C.B.G.); the University of Buffalo, Schools of Medicine and Public Health, Buffalo, NY (W.E.B.); INSERM Unité 698, Université Paris 7, Assistance Publique–Hôpitaux de Paris, Paris (P.G.S.); University Hospital Jean Minjoz, Besançon, France (J.-P.B.); Brigham and Women's Hospital, Boston (D.P.F.); University Hospital Kralovske Vinohrady, Prague (P.W.); Dante Pazzanese Institute of Cardiology, São Paulo (A.A.); Second Medical Clinic, Rüsselsheim, Germany (H.-J.R.); Fu Wai Hospital, Beijing (J.Z.); St. Luc University, Leuven, Belgium (J.C.); and the Royal Infirmary of Edinburgh, University of Edinburgh, Edinburgh (K.A.A.F.).
Address reprint requests to Dr. Mehta at Hamilton General Hospital, McMaster Clinic, Rm. 508, 237 Barton St. E., Hamilton, ON L8L 2X2, Canada, or at smehta{at}mcmaster.ca.
Related Letters:
Acute Coronary Syndromes
Damman P., Tijssen J., de Winter R., Rathod B., Cequier A., Gómez-Hospital J. A., Gonzalez-Costello J., Shojai S., Mehta S. R., Yusuf S., Granger C., Hillis L. D., Lange R. A.
Extract |
Full Text |
PDF
N Engl J Med 2009;
361:925-927, Aug 27, 2009.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |